Cargando…
Experimental Dopamine Reuptake Inhibitors in Parkinson’s Disease: A Review of the Evidence
Parkinson’s disease (PD) is the second most chronic neurodegenerative disorder worldwide. Deficit of monoamines, particularly dopamine, causes an individually varying compilation of motor and non-motor features. Constraint of presynaptic uptake extends monoamine stay in the synaptic cleft. This revi...
Autor principal: | |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8018398/ https://www.ncbi.nlm.nih.gov/pubmed/33824605 http://dx.doi.org/10.2147/JEP.S267032 |